H.C. Wainwright Asserts Buy Rating on Immunitybio Inc. (IBRX) as Net Loss Narrows on Robust Product Revenue

6 days ago 7

Abdul Rahman

Mon, November 24, 2025 astatine 8:47 AM CST 2 min read

Immunitybio Inc. (NASDAQ:IBRX) is one of the fastest-growing penny stocks to bargain now. On November 4, the institution affirmed beardown request for Anktiva, utilized to dainty bladder cancer, arsenic it delivered awesome third-quarter results characterized by robust merchandise sales.

H.C. Wainwright Asserts Buy Rating connected Immunitybio Inc. (IBRX) arsenic Net Loss Narrows connected Robust Product Revenue

The institution delivered merchandise gross of $31.8 million, representing a 434% summation from the 3rd 4th of past year. The year-over-year gross summation came connected the backmost of commercialized traction for ANKTIVA successful operation with BCG successful BCG-unresponsive NMIBC with CIS. Consequently, the company’s gross for the archetypal 9 months of the twelvemonth is up 467% to $74.7 million.

“Unit income grew astir 6X year-to-date compared with full-year 2024, reflecting adoption some astatine starring probe centers and successful assemblage urology clinics, including agrarian areas,” said Richard Adcock, President and CEO of ImmunityBio. “ANKTIVA’s full effect complaint continues to summation momentum with payors arsenic it was precocious added arsenic the preferred cause successful its denotation by a ample medicine contracting enactment covering ~80 cardinal lives.

Amid robust merchandise gross growth, the nett nonaccomplishment shrank to $67.3 million, compared to $85.7 cardinal successful the 3rd 4th of past year. The little nett nonaccomplishment was driven by higher merchandise gross and little related enactment involvement expense.

Following better-than-expected third-quarter results, H.C. Wainwright expert Andres Y. Maldonado reiterated a Buy standing connected the banal and an $8.00 terms target.

Immunitybio Inc. (NASDAQ:IBRX) is simply a biotechnology institution that develops immunotherapy and compartment therapy products to dainty cancers and infectious diseases. The company’s level works to boost the earthy immune strategy to combat disease, with a absorption connected durable, harmless protection.

While we admit the imaginable of IBRX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Top 10 Stocks Offering High Upside Potential successful Data Centers and 10 Best Breakout Stocks to Invest In.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.